The Department of Labor’s arm that oversees employee benefits is adding staff after a year of resignations and retirements, offering clues about the agency’s direction moving forward as it adds public-facing workers and reorients its approach to enforcement.
FDA Commissioner Marty Makary’s departure from the Trump administration is seen as a welcome reset for the pharmaceutical industry after concerns agency decisions lacked scientific rigor and consistency.
Food and Drug Administration Commissioner Marty Makary’s resignation Tuesday was met with relief from a subset of GOP senators who say the doctor froze out the anti-abortion movement.
US Food and Drug Administration Commissioner
The New Hampshire high court struggled at oral arguments Tuesday with the state revenue department’s argument that
Food preservatives, dyes, and other edible chemicals available to consumers are set for increased scrutiny from federal regulators under a new postmarket safety review plan the FDA released Tuesday prioritizing substances posing a possible public health threat.
OptimisCorp came up short in its bid to recoup losses the physical therapy chain blamed on three former executives who refused to turn over millions they won in an arbitration against the company’s ex-lawyer.
The family of a college student said ChatGPT caused their son’s fatal overdose after he followed medical advice about mixing substances from the chatbot, according to a newly filed lawsuit against OpenAI Foundation and Sam Altman.
An HHS proposal to require hospitals and other healthcare facilities to scale up their patient data security infrastructure is drawing criticism over concerns that it could cost billions to implement.
Get the latest legal, regulatory, and enforcement news and analysis, as well as in-depth business and industry covering in the following areas: